Efficacy and Safety of Durvalumab/Tremelimumab in Unresectable Hepatocellular Carcinoma as Immune Checkpoint Inhibitor Rechallenge Following Atezolizumab/Bevacizumab Treatment

Takuya Sho, Goki Suda, Masatsugu Ohara, Risako Kohya, Takashi Sasaki, Sonoe Yoshida, Shunichi Hosoda, Koji Ogawa, Takashi Kitagataya, Osamu Maehara, Shunsuke Ohnishi, Naoki Kawagishi, Mitsuteru Natsuizaka, Masato Nakai, Masaru Baba, Yoshiya Yamamoto, Yoko Tsukuda, Takashi Meguro, Ren Yamada, Tomoe Kobayashi, Tomofumi Takagi, Naoya Sakamoto, for the NORTE STUDY GROUP